Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alzheimer's disease

Retinal thickness measured with optical coherence tomography has been proposed as a noninvasive biomarker for Alzheimer's disease (AD). We therefore measured retinal thickness in well-characterized AD and control participants, considering ophthalmological confounders